Market Mover | Sigma shares surge 23% as the ACCC approves the continuation of the Sigma and CW merger
Market Mover | Sigma shares surge 23% as the ACCC approves the continuation of the Sigma and CW merger
Resistance: A$2.52$Sigma Healthcare Ltd (SIG.AU)$ shares rose 23.39% on Thursday, with trading volume expanding to A$95.71 million. The stock price has reached a new record high. Sigma has risen 24.68% over the past week, with a cumulative gain of 139.57% year-to-date.
$Sigma Healthcare Ltd (SIG.AU)$ 周四，股票上涨23.39%，成交量扩大至A$9571万。股价已达到新的历史高位。Sigma过去一周上涨了24.68%，年初累计涨幅为139.57%。
Sigma's technical analysis chart:
Sigma的技术面分析图表：
Technical Analysis:
技术面分析：
Support: A$1.52
Resistance: A$2.52
Price range A$1.52 to A$2.52: The trading range indicates a heavy concentration of buy orders, with the stock price on an upward trend. The stock repeatedly touched the level near A$1.52, where it found significant support and broke upward. There is a strong presence of buy orders around A$1.52, suggesting a robust foundation for the price. There is considerable upward pressure near the resistance level of A$2.52, with a lot of profit-taking positions, which suggests strong selling pressure. Going forward, it will be crucial to monitor whether the stock can effectively break through the resistance level at A$2.52.
支撑位：A$1.52
支撑位: A$2.52
价格区间 A$1.52 至 A$2.52: 交易范围显示有大量买单集中，股价处于上升趋势。股价反复触及A$1.52附近水平，得到重要支撑并上升。A$1.52附近有大量买单存在，表明价格有坚实的基础。A$2.52附近存在相当大的上行压力，有很多盈利离场位置，这表明有强劲的卖出压力。未来，关键将在于监控股价能否有效突破A$2.52的支撑位。
Market News :
市场资讯：
The ACCC decided not to oppose the merger of Sigma Healthcare Limited and CW Group Holdings Limited, following Sigma's acceptance of a court-enforceable undertaking. On December 11, 2023, the two companies entered into an agreement for Sigma to acquire all Chemist Warehouse shares in a deal valued at A$700 million, comprising Sigma shares and cash. Upon completion, Chemist Warehouse shareholders will own 85.75% of the combined ASX-listed entity, with Sigma shareholders holding the remaining 14.25%. This transaction effectively represents a reverse acquisition of Sigma by Chemist Warehouse.
澳大利亚竞争与消费者委员会（ACCC）决定不反对Sigma Healthcare Limited与CW Group Holdings Limited的合并，因为Sigma接受了一项法院强制执行的承诺。2023年12月11日，两家公司达成协议，Sigma将以价值澳元7千万的交易收购所有Chemist Warehouse股份，其中包括Sigma的股份和现金。交易完成后，Chemist Warehouse股东将拥有合并后在澳交所上市的实体的85.75％，而Sigma股东将持有剩余的14.25％。此交易实际上代表了Chemist Warehouse对Sigma的反向收购。
Overall Analysis:
总体分析：
Fundamentally, focus on the company's performance and operational status. Technically, it is necessary to monitor whether the support at the support level remains valid, and whether the resistance level can be effectively broken through.
从基本面来看，要关注公司的业绩和运营状况。从技术面来看，有必要监测支撑位是否保持有效，并观察是否能有效突破阻力位。
In this scenario, investors should adopt a cautious strategy, setting stop-loss points to manage risk and maintaining ongoing vigilance regarding company developments and market conditions.
在这种情况下，投资者应采取谨慎的策略，设置止损点来管理风险，并对公司发展和市场情况保持持续警惕。
